Drugs / BAX 826
last change Jan 2017 re-read 2 minutes ago

BAX 826

Developed for
hemophilia A
Investigated by
Baxalta now part of Shire

Trials 1 · a red edge is where a trial was stopped

20162017201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT02716194 Mar 2016 → Jan 2017 hemophilia A Baxalta now part of Shire Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as BAX 826 ClinicalTrials.gov intervention name — accepted as the source's own label NCT02716194